A detailed history of Prosight Management, LP transactions in Liva Nova PLC stock. As of the latest transaction made, Prosight Management, LP holds 127,300 shares of LIVN stock, worth $5.79 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
127,300
Previous 70,000 81.86%
Holding current value
$5.79 Million
Previous $3.24 Million 54.27%
% of portfolio
1.78%
Previous 0.96%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$37.02 - $50.73 $2.12 Million - $2.91 Million
57,300 Added 81.86%
127,300 $5 Million
Q4 2024

Feb 14, 2025

SELL
$45.7 - $53.85 $914,000 - $1.08 Million
-20,000 Reduced 22.22%
70,000 $3.24 Million
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $3.9 Million - $4.91 Million
90,000 New
90,000 $4.73 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.44B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.